Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001968749 | SCV002255148 | uncertain significance | Dyskeratosis congenita | 2022-03-29 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1136 of the CTC1 protein (p.Glu1136Lys). This variant is present in population databases (rs761553012, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of CTC1-related conditions (PMID: 30891747). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV001968749 | SCV002531303 | uncertain significance | Dyskeratosis congenita | 2022-02-09 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002484847 | SCV002780052 | uncertain significance | Cerebroretinal microangiopathy with calcifications and cysts 1 | 2021-10-12 | criteria provided, single submitter | clinical testing |